SCHEMBL5879527

SCHEMBL5879527

NCc1cccc(NC(=O)NCc2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
TSHR P16473 1/20 0.61
CYP2C19 P33261 1/20 0.61
KDR P35968 1/20 0.60
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
POLB P06746 1/20 0.57
MAOB P27338 1/20 0.57
HTT P42858 1/20 0.57
MEN1 O00255 1/20 0.57
TP53 P04637 1/20 0.57
HPGD P15428 1/20 0.57
KMT2A Q03164 1/20 0.57
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CA12 O43570 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1206039 0.88 KDR (0.57) KDRNPC1RAB9ASMN1; SMN2POLB
SCHEMBL4743832 0.88 CA2 (0.67) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL17976484 0.87 CFD (0.60) TSHRNPC1RAB9ASMN1; SMN2POLB
SCHEMBL2747411 0.85 DDX3X (0.65) KDRNPC1RAB9ASMN1; SMN2POLB
SCHEMBL2831462 0.84 NPC1 (0.77) NPC1RAB9ASMN1; SMN2POLBMAOB
SCHEMBL17976250 0.83 MAPT (0.50) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL1205996 0.82 NPC1 (0.58) TSHRKDRNPC1RAB9ASMN1; SMN2
SCHEMBL2704691 0.82 MAPT (0.66) KDRNPC1RAB9ASMN1; SMN2POLB
SCHEMBL20804368 0.82 NPC1 (0.65) KDRNPC1RAB9ASMN1; SMN2POLB
SCHEMBL5879548 0.82 CYP1A2 (0.76) CYP1A2CYP2D6CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105508-B1 Integrin receptors antagonists ABBOTT GMBH & CO. KG (DE) 2006-09-12 US disclosed
CN-1374960-A novel integrin receptor antagonists BASF AG (DE) 2002-10-16 CN disclosed
EP-1202988-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2002-05-08 EP disclosed
WO-2001010847-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2001-02-15 WO disclosed